Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02325557 |
| Title | ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Patients With Prostate Cancer - KEYNOTE-046 |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Advaxis, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Recruiting | San Francisco | California | United States | Details | ||
| University of Colorado Health Sciences Center (UCHSC) | Aurora | Colorado | United States | Details | ||
| Recruiting | Rockville | Maryland | United States | Details | ||
| Recruiting | Towson | Maryland | United States | Details | ||
| New Brunswick | New Jersey | United States | Details | |||
| Recrutiing | Philadelphia | Pennsylvania | United States | Details | ||
| Site | Philadelphia | Pennsylvania | United States | Details | ||
| Recruiting | Providence | Rhode Island | United States | Details |